Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
17.60
+0.64 (3.77%)
Nov 1, 2024, 4:00 PM EDT - Market closed
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $26.34 million as of November 1, 2024. Its market cap has increased by 242.12% in one year.
Market Cap
26.34M
Enterprise Value
21.31M
1-Year Change
242.12%
Ranking
Category
Stock Price
$17.60
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $26.34M, a decrease of -54.72%. That is a compound annual growth rate of -35.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 1, 2024 | 18.80M | 95.83% |
Dec 29, 2023 | 9.60M | -83.50% |
Jan 20, 2023 | 58.17M | - |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Spectral AI | 27.21M |
OneMedNet | 27.05M |
Bionano Genomics | 27.03M |
CytoMed Therapeutics | 26.60M |
Pluri | 26.53M |
Lisata Therapeutics | 26.29M |
Estrella Immunopharma | 26.27M |
BioXcel Therapeutics | 26.20M |